NCT05393388View on ClinicalTrials.gov

Tau Pet Imaging in the Aging Brain Cohort Dedicated to Diversity Study

RecruitingOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

May 9, 2022

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Cognitive DeclineAlzheimer Disease
Interventions
DRUG

[18F]AV-1451

\[18F\]AV-1451 has been developed as a positron emitting radiopharmaceutical for in vivo imaging of tau protein aggregates.

Trial Locations (1)

19104

RECRUITING

Hospital of the University of Pennsylvania - Penn Memory Center, Philadelphia

All Listed Sponsors
collaborator

Pennsylvania Department of Health

OTHER_GOV

lead

University of Pennsylvania

OTHER